Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands

Clinical Cancer Research

Volumn 14, Issue 16, 2008, Pages 5181-5187

  Rao, Pulivarthi H ^a   Roberts, Diana ^b   Zhao, Yi Jue ^a   Bell, Diana ^b   Harris, Charles P ^c   Weber, Randal S ^a   El Naggar, Adel K ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c M D Anderson Cancer Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 12Q; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SALIVARY GLAND CANCER; CHROMOSOME 1; GENE DELETION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; SALIVARY GLAND TUMOR;

TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, ADENOID CYSTIC; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SEQUENCE DELETION; TUMOR MARKERS, BIOLOGICAL;

EID: 52649168940     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0158     Document Type: Article

References (28)

1. Fordice J, Kershaw C, EI-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999;125:149-52.
2. Bradley PJ. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 2004;12:127-32.
3. Wiseman SM, Popat SR, Rigual NR, et al. Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases. Ear Nose Throat J 2002;81:510-8.
4. Chummun S, McLean NR, Kelly CG, et al. Adenoid cystic carcinoma of the head and neck. Br J Plast Surg 2001;54:476-80.
5. Khan AJ, DiGiovanna MP, Ross DA, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer 2001;96:149-58.
6. Ensley JF. Clinical perspectives in head and neck cancer. In: Ensley JF, Gutkind JS, Jacobs JR, Lippman SM, editors. Head and neck cancer: Emerging perspectives. San Diego: Academic Press; 2003. p. 16-22.
7. Batsakis JG, Luna MA, el-Naggar A. Histopathologic grading of salivary gland neoplasms: III Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol 1990;99:1007-9.
8. Slichenmyer WJ, LeMaistre CF, Von Hoff DD. Response of metastatic adenoid cystic carcinoma and Merkel cell tumor to high-dose melphalan with autologous bone marrow transplantation. Invest New Drugs 1992;10:45-8.
9. Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995;32:619-26.
10. Nordkvist A, Mark J, Gustafsson H, Bang G, Stenman G. Non-random chromosome re-arrangements in adenoid cystic carcinoma of the salivary glands. GenesChromosomesCancer1994;10:115-21.
11. Higashi K, Jin Y, Johansson M, et al. Rearrangement of 9p13 as the primary chromosomal aberration in adenoid cystic carcinoma of the respiratory tract. Genes Chromosomes Cancer 1991;3:21-3.
12. El-Rifai W, Rutherford S, Knuutila S, Frierson HF, Jr., Moskaluk CA. Novel DNA copy number losses in chromosome 12q12-13 in adenoid cystic carcinoma. Neoplasia 2001;3:173-8.
13. Freier K, Flechtenmacher C, Walch A, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet 2005;159:89-95.
14. Vékony H, Ylstra B,Wilting SM, et al. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res 2007;13:3133-9.
15. Yamamoto Y, Virmani AK, Wistuba II, et al. Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glands. Hum Pathol 1996;27:1204-10.
16. Kishi M, Nakamura M, Nishimine M, et al. Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas. Cancer Sci 2003;94:530-5.
17. Rutherford S, Hampton GM, Frierson HF, Moskaluk CA. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma. Lab Invest 2005;85:1076-85.
18. Rutherford S,Yu Y, Rumpel CA, Frierson HF, Jr., Moskaluk CA. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett 2006;236:309-17.
19. Suzuki N, Onda T, Yamamoto N, Katakura A, Mizoe JE, Shibahara T. Mutation of the p16/CDKN2 gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck. Int J Oncol 2007;31:1061-7.
20. Patel KJ, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM. Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. Oral Oncol 2006:42:994-4.
21. Frierson H, El-Naggar A, Welsh J, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002;161:1315-23.
22. Singh B, Gogineni SK, Sacks PG, et al. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 2001;61:4506-13.
23. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, Jonasson JG, Egilsson V, Ingvarsson S. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 1999; 79:1468-74.
24. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-19.
25. Corn PG, Kuerbitz SJ, van Noesel MM, et al. Transcriptional silencing of the p73 gene in Acute Lymphoblastic Leukemia and Burkitt's Lymphoma is associated with 5′ CpG island methylation. Cancer Res 1999;59:3352-6.
26. Bagchi A, Papazoglu C, Wu Y et al CHD5 is a tumor suppressor at human 1p36. Cell 2007;128:459-75.
27. Jost CA, Marin MC, Kaelin WG, Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997;389:191-4.
28. Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 2003;22:1002-11.